Results 11 to 20 of about 573,829 (353)

Postoperative adjuvant therapy [PDF]

Journal of Hepato-Biliary-Pancreatic Sciences, 2011
AbstractAfter a lengthy search for an effective treatment for resected pancreatic cancer, evidence accumulated in the past 10 years shows that adjuvant chemotherapy is firmly established as offering a modest but real improvement in overall survival.
Tomoo, Kosuge, Yoshihiro, Sakamoto, Hideki, Ueno   +2 more
openaire   +2 more sources

Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study

Frontiers in Oncology, 2023
BackgroundCholangiocarcinoma (CCA) is a highly heterogeneous malignant tumor, and more than 60% of patients have recurrence and metastasis after surgery. The efficacy of postoperative adjuvant therapy for CCA remains unclear.
Zhongquan Sun, Zhongquan Sun, Zhongquan Sun, Zhongquan Sun, Zhongquan Sun, Zhongquan Sun, Xin Han, Xin Han, Xin Han, Xin Han, Xin Han, Xin Han, Wanlu You, Wanlu You, Wanlu You, Wanlu You, Wanlu You, Wanlu You, Jinlong Tang, Juehua Xu, Juehua Xu, Juehua Xu, Juehua Xu, Juehua Xu, Juehua Xu, Binglin Ye, Binglin Ye, Binglin Ye, Binglin Ye, Binglin Ye, Binglin Ye, Tengfei Li, Tengfei Li, Tengfei Li, Tengfei Li, Tengfei Li, Tengfei Li, Yixin Zhang, Yixin Zhang, Yixin Zhang, Yixin Zhang, Yixin Zhang, Yixin Zhang, Kai Chen, Kai Chen, Kai Chen, Kai Chen, Kai Chen, Kai Chen, Yuan Ding, Yuan Ding, Yuan Ding, Yuan Ding, Yuan Ding, Yuan Ding, Weilin Wang, Weilin Wang, Weilin Wang, Weilin Wang, Weilin Wang, Weilin Wang   +60 more
doaj   +1 more source

Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate‐risk group

Cancer Medicine, 2023
Background The efficacy of adjuvant therapy for patients with cervical cancer with intermediate risk (CC‐IR) remains controversial. We examined the impact of adjuvant therapy on survival outcomes in patients with CC‐IR and evaluated the heterogeneous ...
Ayumi Taguchi, Kosuke Kato, Konan Hara, Akiko Furusawa, Yujiro Nakajima, Chihiro Ishizawa, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori, Muneaki Shimada, Aikou Okamoto, Munetaka Takekuma   +11 more
doaj   +1 more source

Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma [PDF]

, 2019
BACKGROUND: Meningiomas are the most common primary tumors of the central nervous system. In patients with WHO grade I meningiomas no adjuvant therapy is recommended after resection.
Acker, Güliz, Badakhshi, Harun, Budach, Volker, Ghadjar, Pirus, Grün, Arne, Hemmati, Saman Moritz, Kaul, David, Misch, Martin, Senger, Carolin, Zschaeck, Sebastian   +9 more
core   +1 more source

Augmented Features Synergize Radiomics in Post-Operative Survival Prediction and Adjuvant Therapy Recommendation for Non-Small Cell Lung Cancer

Frontiers in Oncology, 2022
BackgroundOwing to the cytotoxic effect, it is challenging for clinicians to decide whether post-operative adjuvant therapy is appropriate for a non-small cell lung cancer (NSCLC) patient. Radiomics has proven its promising ability in predicting survival
Lawrence Wing-Chi Chan, Tong Ding, Huiling Shao, Mohan Huang, William Fuk-Yuen Hui, William Chi-Shing Cho, Sze-Chuen Cesar Wong, Ka Wai Tong, Keith Wan-Hang Chiu, Luyu Huang, Luyu Huang, Haiyu Zhou, Haiyu Zhou   +12 more
doaj   +1 more source

Adherence to adjuvant therapy in post-menopausal breast cancer patients: A review [PDF]

, 2011
This is the post-print version of the Article. The official published version can be accessed from the link below - Copyright @ 2012 John Wiley & Sons, IncThis review aimed to address the concept of adherence to adjuvant therapy in post-menopausal women.
Banning, M
core   +1 more source

Duration of adjuvant chemotherapy for stage III colon cancer [PDF]

, 2018
BACKGROUND Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard adjuvant therapy in patients with stage III colon cancer.
Andre, Thierry, Boukovinas, Ioannis, Grothey, Axel, Iveson, Timothy, Kerr, Rachel, Labianca, Roberto, Meyerhardt, Jeffrey A., Meyers, Jeffrey P., Niedzwiecki, Donna, Paul, James, Renfro, Lindsay A., Sargent, Daniel J., Saunders, Mark, Shi, Qian, Shields, Anthony F., Sobrero, Alberto F., Souglakos, John, Taieb, Julien, Torri, Valter, Vernerey, Dewi, Watanabe, Toshiaki, Yamanaka, Takeharu, Yoshino, Takayuki   +22 more
core   +1 more source

Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011) [PDF]

, 2011
Every 2 years, the International Consensus Conference on the Treatment of Primary Breast Cancer takes place in St. Gallen. Given that the concept of the St.
Beckmann, Matthias W., Blohmer, Jens-Uwe, Costa, Serban-Dan, Diedrich, Klaus, Diel, Ingo, Eiermann, Wolfgang, Friese, Klaus, Gerber, Bernd, Harbeck, Nadia, Hilfrich, Jörn, Jackisch, Christian, Janni, Wolfgang, Jonat, Walter, Jänicke, Fritz, Kaufmann, Manfred, Kiechle, Marion, Kreienberg, Rolf, Köhler, Uwe, Maass, Nicolai, Marschner, Norbert, Minckwitz, Gunter von, Möbus, Volker, Nitz, Ulrike, Scharl, Anton, Schneeweiss, Andreas, Thomssen, Christoph, Untch, Michael, Wallwiener, Diethelm   +27 more
core   +1 more source

Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma. [PDF]

PLoS ONE, 2018
OBJECTIVE:The role of adjuvant therapy in small bowel adenocarcinoma (SBA), a rare malignancy with a poor prognosis, is controversial. The purpose of this article is to investigate the impact of adjuvant therapy on the survival of patients with SBA in a ...
Xiaojian Ye, Guoqiang Zhang, Haibin Chen, Yong Li   +3 more
doaj   +1 more source

Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX

Frontiers in Oncology, 2022
BackgroundThe complete resection rate of pancreatic cancer has increased because of the advent of efficacious first-line treatments for unresectable pancreatic cancer.
Jin Ho Choi, Min Kyu Kim, Sang Hyub Lee, Jin Woo Park, Namyoung Park, In Rae Cho, Ji Kon Ryu, Yong-Tae Kim, Jin-Young Jang, Wooil Kwon, Hongbeom Kim, Woo Hyun Paik   +11 more
doaj   +1 more source